Experienced Representation For Food Contact Materials Approval Issues

Food packaging is as heavily regulated as the food it contains. Every substance in packaging is subject to rigorous food contact compliance requirements. Food and Drug Administration (FDA) requirements are complex and evolve over time, and it can be difficult for suppliers, converters, manufacturers and end users to keep track.

At the law firm of Eric F. Greenberg, P.C., we have extensive experience advising clients on a variety of issues involving the review, evaluation and FDA approval of food contact materials. Attorney Greenberg is widely recognized for his comprehensive knowledge in this area and his ability to provide sound and timely solutions.

Providing Timely Advice In An Ever-Changing Environment

We are familiar with the ongoing developments in the food contact materials arena. We stay abreast of developments relating to active and intelligent packaging, nanotechnology and other emerging areas so that we can effectively advise our clients with regard to the regulatory status of various components and address any related issues.

Our experience and understanding of the regulatory requirements in these areas allow us to provide innovative solutions to our clients’ needs. From writing opinion letters regarding the compliance of a particular material to petitioning the Food and Drug Administration (FDA) for approval of a new use, we are prepared to provide the effective representation our clients require.

Discuss Your Questions With A Qualified Lawyer

From our office in Chicago, Illinois, we represent clients throughout the United States and around the world in complex food contact materials issues. Contact our office to speak with an attorney about your legal issue. You can reach us by phone at 312-977-4647 or send us an email.

Food Section

Why Would FDA’s Emergency Actions Stick Around After the Emergency is Over?

Why Would FDA’s Emergency Actions Stick Around After the Emergency is Over?

By Eric F. Greenberg, Attorney-at-law

While some of the Food and Drug Administration’s actions in response to COVID-19 have been traditional, many others have been simplifications of regulatory requirements, and those simplifications could be made permanent.

Here’s one type of activity that was traditional: The agency has been slapping down phony drug products. The moment the COVID-19 pandemic hit the scene, dietary supplement products claiming to cure or prevent the virus started to be offered for sale, and immediately FDA and the Federal Trade Commission started making a regular habit of issuing stern warnings to the makers of the products.

You have questions, We have answers. Request a consult.

Our Office Location

303 East Wacker Drive Suite 305
Chicago, IL 60601

Phone: 312-977-4647